Category: biomarkers

Introduction Picture this: a groundbreaking treatment revolutionizing the care of patients with Neuroendocrine Tumors (NETs). Enter Cabozantinib, a beacon of hope in the realm of precision medicine. Recent studies have shed light on how this drug interacts differently with various subsets of NETs patients, offering targeted benefits and improved outcomes. Let’s delve into the exciting […]

In the realm of cardiovascular research, a recent study has shed light on the intriguing role of Growth Differentiation Factor 15 (GDF-15) in predicting short-term adverse outcomes in patients with suspected Acute Coronary Syndrome (ACS). This groundbreaking research not only adds a new layer of understanding to the intricate web of cardiac biomarkers but also […]

In critical illness, the body’s immune response plays a crucial role in determining treatment outcomes. Recent advancements in biotechnology have enabled scientists to decode immune signatures, offering valuable insights into how patients respond to treatment and recover from severe conditions. By analyzing these immune signatures, researchers can identify biomarkers that predict patient outcomes and tailor […]

In the realm of biotechnology, the quest for noninvasive diagnostics has been a driving force, propelling researchers to explore innovative avenues for biomarker discovery. With the potential to revolutionize healthcare by enabling early disease detection and personalized treatment strategies, the study of biomarkers in breath and biofluids has garnered significant attention in recent years. This […]

A groundbreaking study presented at the American Neurologic Association annual meeting sheds light on the potential of a virtual reality eye-tracking device in assessing the cognitive recovery of athletes following mild traumatic brain injury (TBI). The research, conducted by Betania Arce and colleagues from the department of biomedical engineering at Johns Hopkins University, introduces a […]

In a groundbreaking discovery, researchers have pinpointed SLIT2 protein levels in the eye and blood as a pivotal biomarker for predicting cognitive performance in middle-aged adults. This new revelation sheds light on the correlation between lower SLIT2 levels in the vitreous humor and higher SLIT2 levels in plasma with diminished memory and overall cognitive function. […]

In the realm of multiple sclerosis (MS) research, a groundbreaking study has shed light on a crucial aspect of the disease – the progression independent of relapse activity (PIRA), identified as the primary driver of disability. The study, led by Federico Burguet Villena and his team at University Hospital Basel, Switzerland, delves into the power […]

At Analytica USA 2025, Martin Gilar, a distinguished Research Fellow within the Separations R&D Group at Waters Corporation, took center stage in Columbus, Ohio. His captivating presentation, “RNA Analysis with LC and Affinity LC Methods,” delved into the realm of mass spectrometry as a potent tool for dissecting various RNA species. The complexity of long […]

Chronic insomnia, a sleep disorder characterized by difficulty falling and staying asleep, has long been associated with various health concerns, including cognitive decline, dementia, and Alzheimer’s disease. Recent studies have shed light on the significant impact of chronic insomnia on brain health, revealing a potential 40% increase in the risk of developing dementia and mild […]

In the realm of neurodegenerative diseases, Alzheimer’s poses a significant challenge due to its insidious nature, often remaining undetected until irreversible damage is done. However, a groundbreaking study at the University of California, San Diego has shed light on a potential game-changer: a simple blood test that could unveil warning signs of Alzheimer’s years before […]

In the realm of cognitive health, the interplay between nutrition, inflammation, and neurodegeneration has emerged as a critical area of research. The quest to identify biomarkers that can provide insight into the risk of cognitive decline has led to a focus on minimally invasive measures, particularly in the plasma. The intricacies of this relationship were […]

Living with multiple sclerosis (MS) is a challenging journey filled with unpredictable symptoms and the looming threat of disability progression. The quest for effective and personalized treatment is a constant battle, especially with the risks associated with high-intensity therapies. Fortunately, the emergence of biomarkers like neurofilament light chain and glial fibrillary acidic protein is revolutionizing […]

Biomarker testing stands at the core of successful targeted and immunotherapy development in the biopharma industry. From the initial stages of discovery to the final commercialization of a product, the strategic integration of biomarkers plays a crucial role in accelerating research and development processes, enhancing patient stratification, and reducing risks associated with clinical trials. By […]

The latest developments in separation science have been at the forefront this week, with LCGC International releasing a range of articles covering key topics in chromatography. From discussions on the impact of U.S. research funding cuts to insights into the newest HPLC products in the market, the focus remains on sharing cutting-edge advancements in chromatography. […]

Adults diagnosed with spinal and bulbar muscular atrophy (SBMA) may have a vital window into their disease progression through the levels of nerve proteins in their cerebrospinal fluid (CSF). A recent study discovered that SBMA patients exhibit heightened levels of neurofilament light (NfL) chain and glial fibrillary acidic protein (GFAP) in their CSF, indicating nerve […]

Oxidative stress, characterized by an imbalance between oxidants and antioxidants favoring oxidants, impacts redox signaling by modifying specific proteins through reversible alterations like S-nitrosylation and disulfide bonds. This imbalance can lead to disruptions in cellular functions, making oxidative stress a critical factor in various diseases. However, the lack of validated oxidative stress biomarkers has been […]

A recent study published in the Clinical Journal of the American Society of Nephrology has shed light on the significance of urinary epidermal growth factor (EGF) as a promising biomarker for protecting against chronic kidney disease (CKD) progression. Conducted by Dr. Sarah J. Schrauben and her team from the University of Pennsylvania, the research explored […]